Chemistree Technology terminates The Physician's Choice CBD investment
Chemistree Technology Inc (CSE:CHM) (OTCMKTS:CHMJF) told investors Tuesday it had cancelled its earlier announced planned investment into The Physician’s Choice CBD (PCCBD) of Phoenix, Arizona.
As reported back in April, The Physician’s Choice CBD is a medical doctor-led company with a portfolio of nine hemp-derived CBD products that target pain management and wellness supplements.
READ: Chemistree says cannabis licensee partner in Washington State has full order book and is eyeing expansion
“I am disappointed to report that after many months of meetings, discussions and attempts to manage an increasingly frustrating process, Chemistree has decided that the proposed $1 million investment into what we believed was a compelling and unique company, cannot be made,” said Karl Kottmeier, Chemistree president in a brief statement.
“While scientifically excellent, our due diligence identified significant issues with PCCBD management. We ultimately determined that we could not arrive at a go forward plan, nor a definitive agreement and accordingly the proposed arrangement has been terminated, with no funds having been forwarded.”
Chemistree is an investor in the U.S. cannabis sector and its strategy is to acquire and develop vertically integrated assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities.
In September this year, the firm said its Sugarleaf brand in Washington State had booked strong sales and is looking at expanding to keep up with rocketing demand for its products.
Different strains
Sugarleaf has 18 different strains of high-quality cannabis being grown in rotation, including nine major strains and nine minor strains in smaller-batch production.
Chemistree said that Sugarleaf saw a 30% sales increase from April, a 36% rise in crop yield, and a 100% boost in retail client stores.
“These numbers are surpassing my expectations and I am really proud of the team at Sugarleaf for their focus on producing a high-quality cultivated product,” said chief cannabis officer Sheldon Aberman, who is also a board member of Chemistree Technology.
Story by ProactiveInvestors
Source: https://www.proactiveinvestors.com/companies/news/904391/chemistree-technology-terminates-the-physician-s-choice-cbd-investment-904391.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).